期刊文献+

二噁英受体的配体多样性研究进展

Research progress on ligand diversity of aryl hydrocarbon receptor
下载PDF
导出
摘要 二噁英受体(AHR)是一种依赖于配体激活的转录因子,在细胞增殖与分化、细胞凋亡、癌细胞迁移以及炎症反应等多种生物学过程中具有至关重要的作用。AHR的激活依赖于外界环境中的多种有毒化合物或内源性配体的结合,不同类型配体通过激活AHR的不同信号通路发挥不同的功能。对不同结合位点的AHR配体分子进行归纳、总结,并对几类典型的激动剂和拮抗剂激活AHR的机制及其在不同疾病中的潜在毒理作用进行综述。深入了解AHR的激活机制及其毒理作用将有助于预防和治疗环境污染物所导致的疾病,并为以AHR为靶点的药物开发提供一定的理论指导。 Aryl hydrocarbon receptor(AHR)is a ligand-dependent activated transcription factor with critical roles in a variety of biological processes,including cell proliferation,differentiation,apoptosis,cancer migration and inflammation.The activation of AHR depends on the binding of various toxic compounds in the external environment or endogenous ligands.Different types of ligands mediate different signaling pathways of AHR and perform different functions.In this paper,the AHR ligands with different binding sites was concluded,and the molecular mechanisms of AHR activation by several typical agonists and antagonists were summarized.Furthermore,the potential toxicological effects in different diseases and tumors were reviewed.An in-depth understanding of the activation mechanisms and toxicological effects of AHR will help prevent and treat the development of diseases caused by environmental pollutants and provide some theoretical guidance for the development of drugs targeting AHR.
作者 董敏敏 严汉池 DONG Minmin;YAN Hanchi(Colleg of Life Sciences,Tianjin University,Tianjin 310110)
出处 《环境污染与防治》 CAS CSCD 北大核心 2023年第3期400-407,共8页 Environmental Pollution & Control
基金 国家自然科学基金资助项目(No.32071216、No.31870742) 环境化学与生态毒理学国家重点实验室开放基金资助项目(No.KF2020-15)。
关键词 二噁英受体 激动剂 拮抗剂 癌症治疗 aryl hydrocarbon receptor agonist antagonist cancer therapy
  • 相关文献

参考文献1

二级参考文献39

  • 1[1]Rex DK,Kahi CJ,Levin B,Smith RA,Bond JH,Brooks D,Burt RW,Byers T,Fletcher RH,Hyman N,Johnson D,Kirk L,Lieberman DA,Levin TR,O'Brien MJ,Simmang C,Thorson AG,Winawer SJ.Guidelines for colonoscopy surveillance after cancer resection:a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer.Gastroenterology 2006; 130:1865-1871
  • 2[2]Berman JM,Cheung RJ,Weinberg DS.Surveillance after colorectal cancer resection.Lancet 2000; 355:395-399
  • 3[3]Lacy AM,Garcia-Valdecasas JC,Delgado S,Castells A,Taura P,Pique JM,Visa J.Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer:a randomised trial.Lancet 2002; 359:2224-2229
  • 4[4]Weitz J,Koch M,Debus J,Hohler T,Galle PR,Buchler MW.Colorectal cancer.Lancet 2005; 365:153-165
  • 5[5]Winawer SJ,Zauber AG,Fletcher RH,Stillman JS,O'Brien MJ,Levin B,Smith RA,Lieberman DA,Burr RW,Levin TR,Bond JH,Brooks D,Byers T,Hyman N,Kirk L,Thorson A,Simmang C,Johnson D,Rex DK.Guidelines for colonoscopy surveillance after polypectomy:a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.Gastroenterology 2006; 130:1872-1885
  • 6[6]Bingham SA,Day NE,Luben R,Ferrari P,Slimani N,Norat T,Clavei-Chapelon F,Kesse E,Nieters A,Boeing H,Tjonneland A,Overvad K,Martinez C,Dorronsoro M,Gonzalez CA,Key TJ,Trichopoulou A,Naska A,Vineis P,Tumino R,Krogh V,Bueno-de-Mesquita HB,Peeters PH,Berglund G,Hallmans G,Lund E,Skeie G,Kaaks R,Riboli E.Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC):an observational study.Lancet 2003; 361:1496-1501
  • 7[7]Alberta DS,Martinez ME,Roe DJ,Guillen-Rodriguez JM,Marshall JR,van Leeuwen JB,Reid ME,Ritenbaugh C,Vargas PA,Bhattacharyya AB,Earnest DL,Sampliner RE.Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas.Phoenix Colon Cancer Prevention Physicians1 Network.N Engl J Med 2000; 342:1156-1162
  • 8[8]Schatzkin A,Lanza E,Corle D,Lance P,Iber F,Caan B,Shike M,Weissfeld J,Burr R,Cooper MR,Kikendall JW,Cahill J.Lack of effect of a low-fat,high-fiber diet on the recurrence of colorectal adenomas.Polyp Prevention Trial Study Group.N Engl J Med 2000; 342:1149-1155
  • 9[9]Greenberg ER,Baron JA,Tosteson TD,Freeman DH Jr,Beck GJ,Bond JH,Colacchio TA,Coller JA,Frankl HD,Halle RW.A clinical trial of antioxidant vitamins to prevent colorectal adenoma.Polyp Prevention Study Group.N Engl J Med 1994;331:141-147
  • 10[10]World Cancer Research Fund/American Institute for Cancer Research.Food,Nutrition,Physical Activity,and thePrevention of Cancer:A Global Perspective.Washington,DC:AICR,2007:280-288

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部